glp-1 names receptor agonist drug GLP-1 Receptor Agonists: An Alternative for Rapid-Acting Insulin? The glucagon-like peptide 1 receptor
Description
at least 50% of patients receiving 10 or 15 mg of tirzepatide per week achieved a weight loss of 20% and more 6,59,60,61,62 .Tirzepatide was also superior to semaglutide at reducing levels of glycated hemoglobin 63
Other side effects include diarrhoea (up to 30% on semaglutide and 20% on tirzepatide), vomiting (25% vs 12% respectively), constant sinusistis/pharyngitis (up to 20%), headaches (15% vs 6%), abdominal pain (10% vs 5%)
In the analysis of different types of GLP-1 receptor agonists, we found that liraglutide and dulaglutide were significantly associated with an increased risk of overall thyroid disorders
That compared to a 2.2 percent decrease for participants taking an oral placebo pill
And when Novo Nordisk faced production issues, the decision to choose Eli Lilly's Mounjaro and Zepbound over Novo Nordisk's Wagovy became even easier
But these studies examined substances one at a time
